SCHEMBL8935259

SCHEMBL8935259

NCCC(=O)NCc1ccc(OCc2cccnc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.57
HTT P42858 1/20 0.57
MAPT P10636 2/20 0.56
MAPK1 P28482 3/20 0.55
MMP13 P45452 1/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54
LMNA P02545 2/20 0.52
RECQL P46063 2/20 0.52
CYP2D6 P10635 1/20 0.52
ADAMTS5 Q9UNA0 1/20 0.51
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 1/20 0.49
RAB9A P51151 1/20 0.49
ACACB O00763 1/20 0.49
KDM4E B2RXH2 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8935330 0.86 EPHX2 (0.57) SMN1; SMN2MAPTMAPK1LMNARECQL
SCHEMBL8234001 0.84 CYP3A4 (0.81) CYP3A4SMN1; SMN2HTTMAPTCYP1A2
SCHEMBL8935268 0.81 MMP13 (0.58) CYP3A4SMN1; SMN2HTTMAPTMAPK1
SCHEMBL8935404 0.79 PARP10 (0.56) SMN1; SMN2HTTMAPTCYP1A2CYP2C19
SCHEMBL8935236 0.78 MAOB (0.63)
SCHEMBL8935322 0.78 GID4 (0.71) SMN1; SMN2HTTCYP1A2CYP2C9CYP2C19
SCHEMBL23291320 0.77 CHRNA7 (0.64) MAPK1
SCHEMBL1274303 0.77 RECQL (0.71) CYP3A4SMN1; SMN2HTTMAPTCYP1A2
SCHEMBL16610098 0.77 MAPT (0.84) CYP3A4SMN1; SMN2HTTMAPTCYP1A2
SCHEMBL1881696 0.77 CYP3A4 (0.97) CYP3A4SMN1; SMN2HTTMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5502079-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS FARMITALIA CARLO ERBA S.R.L. (IT) 1996-03-26 US disclosed